Flagship Biosciences has filed a notice of an exempt offering of securities to raise $6,369,795.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Flagship Biosciences is raising up to $6,369,795.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Trevor Johnson played a…